Published in Clin Colon Rectal Surg on August 01, 2005
Colorectal cancer: Metastases to a single organ. World J Gastroenterol (2015) 0.97
S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Exp Cell Res (2013) 0.85
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment. Onco Targets Ther (2016) 0.78
Bone Marrow Adipose Tissue: A New Player in Cancer Metastasis to Bone. Front Endocrinol (Lausanne) (2016) 0.77
FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION. Arq Bras Cir Dig (2015) 0.76
Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis. Int J Colorectal Dis (2016) 0.75
The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. FEBS Lett (2015) 0.75
First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastases. Cancer Biol Ther (2016) 0.75
Metastatic Tissue Proteomic Profiling Predicts 5-Year Outcomes in Patients with Colorectal Liver Metastases. Transl Oncol (2016) 0.75
Blocking hepatic metastases of colon cancer cells using an shRNA against Rac1 delivered by activatable cell-penetrating peptide. Oncotarget (2016) 0.75
Enhanced colorectal cancer metastases in the alcohol-injured liver. Clin Exp Metastasis (2017) 0.75
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg (2000) 3.97
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ (1993) 3.26
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol (1999) 2.61
Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol (2000) 2.51
A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol (1976) 2.42
Computed tomographic portography in preoperative imaging of hepatic neoplasms. Br J Surg (1995) 2.31
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg (2003) 2.06
The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg (1979) 1.93
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol (2005) 1.92
Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol (1992) 1.91
Occult hepatic metastases in colorectal carcinoma. Br J Surg (1986) 1.90
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol (2003) 1.63
Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg (2001) 1.54
The National Cancer Data Base. Report on colon cancer. Cancer (1996) 1.53
THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUM. Am J Surg (1964) 1.51
Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet (1970) 1.48
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound (2003) 1.43
Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg (2002) 1.42
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery (1995) 1.21
Radiofrequency ablation for malignant liver tumor. Surg Oncol (2005) 1.12
Resection and embolization in the management of secondary hepatic tumors. World J Surg (1982) 1.11
Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery (2002) 1.09
Repeat hepatic resections for metastatic colorectal cancer. Ann Surg (1994) 1.05
Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg (2004) 1.03
Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology (1992) 1.02
Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Cancer Treat Rev (2004) 1.02
Hepatic colorectal metastasis: current status of surgical therapy. Oncology (Williston Park) (1998) 0.96
Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg (2004) 0.94
Prognostic factors for survival and disease-free survival in hepatic metastases from colorectal cancer treated by resection. Tumori (1995) 0.89
Current techniques and results of liver resection for colorectal liver metastases. Br Med Bull (2004) 0.81
Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg (1993) 0.80
Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg (2003) 0.79
CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer. Eur J Cancer (1996) 0.77
Intra-abdominal extrahepatic disease in patients with colorectal hepatic metastases. Dis Colon Rectum (1988) 0.76
CT during arterial portography: comparison of injection into the splenic versus superior mesenteric artery. Radiology (1996) 0.76
Survival benefit of repeat liver resection for recurrent colorectal metastases: 143 cases. Wiad Lek (1997) 0.76
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg (2007) 2.62
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol (2007) 2.26
Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13
A role for hepatic metastasectomy in stage IV melanoma and breast cancer: reestablishing the surgical modality. Oncology (Williston Park) (2011) 2.04
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol (2005) 1.88
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys (2008) 1.83
Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol (2006) 1.70
The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol (2012) 1.66
Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann Surg Oncol (2006) 1.62
Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res (2011) 1.58
Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10,206 patients. JAMA Surg (2013) 1.58
Resident education in the era of patient safety: a nationwide analysis of outcomes and complications in resident-assisted oncologic surgery. Ann Surg Oncol (2013) 1.52
Pancreatic duct strictures: identifying risk of malignancy. Ann Surg Oncol (2004) 1.52
In vivo selection of tumor-targeting RNA motifs. Nat Chem Biol (2009) 1.36
Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol (2011) 1.31
Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys (2005) 1.28
Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res (2007) 1.27
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol (2006) 1.21
Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg (2007) 1.19
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer (2012) 1.16
RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Mol Ther (2007) 1.14
Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg (2012) 1.14
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg (2014) 1.11
Examining reoperation and readmission after hepatic surgery. J Am Coll Surg (2013) 1.10
Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.10
Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. J Am Coll Surg (2007) 1.09
H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res (2006) 1.09
Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol (2007) 1.07
Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis. Biol Chem (2009) 1.05
Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer. J Surg Res (2007) 1.05
Major liver resection in elderly patients: a multi-institutional analysis. J Am Coll Surg (2011) 1.05
Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. J Surg Res (2004) 1.03
A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford) (2011) 1.03
Workforce projections for hepato-pancreato-biliary surgery. J Am Coll Surg (2008) 1.02
Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer (2011) 1.02
Histological and molecular evaluation of patient-derived colorectal cancer explants. PLoS One (2012) 1.01
Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol (2009) 1.00
Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem Biophys Res Commun (2005) 1.00
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? J Surg Oncol (2012) 1.00
Aptamer applications for targeted cancer therapy. Future Oncol (2010) 1.00
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol (2008) 0.99
Extended resection for pancreatic adenocarcinoma. Oncologist (2007) 0.99
Surgical management of gallbladder cancer. Surg Oncol Clin N Am (2009) 0.99
Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg (2011) 0.98
Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol (2007) 0.97
Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. J Am Geriatr Soc (2011) 0.96
Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery (2013) 0.96
Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw (2014) 0.93
Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy. Ann Surg Oncol (2014) 0.93
Liver transplantation for glycogen storage disease type Ia. J Hepatol (2009) 0.92
Incidence of benign disease in patients that underwent resection for presumed pancreatic cancer diagnosed by endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA). J Gastrointest Surg (2010) 0.92
Regionalization of hepatic resections is associated with increasing disparities among some patient populations in use of high-volume providers. J Am Coll Surg (2008) 0.91
Dual-phase 3D MDCT angiography for evaluation of the liver before hepatic resection. AJR Am J Roentgenol (2004) 0.91
NF-kappaB inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosis. Biochem Biophys Res Commun (2007) 0.91
Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.90
Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg (2014) 0.88
Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg (2002) 0.87
Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg (2002) 0.86
Extended hepatic resection for gallbladder cancer. Am J Surg (2007) 0.85
Pancreaticoduodenectomy: frequency and outcome of post-operative imaging-guided percutaneous drainage. Abdom Imaging (2009) 0.84
Neuroendocrine liver metastases. Surg Clin North Am (2010) 0.83
Feeding jejunostomy tube placement in patients undergoing pancreaticoduodenectomy: an ongoing dilemma. J Gastrointest Surg (2014) 0.83
Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment. Curr Oncol Rep (2014) 0.83
Vascular surgery collaboration during pancreaticoduodenectomy with vascular reconstruction. Ann Vasc Surg (2012) 0.83
Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. HPB (Oxford) (2009) 0.82
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram. Ann Surg Oncol (2006) 0.82
Venous thromboembolism after hepatic resection: analysis of 5,706 patients. J Gastrointest Surg (2012) 0.81
Hepatic parenchymal transection with vascular staplers: a comparative analysis with the crush-clamp technique. Am J Surg (2008) 0.81
Defining criteria for selective operative management of pancreatic cystic lesions: does size really matter? J Gastrointest Surg (2010) 0.81
Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer. J Gastrointest Surg (2012) 0.80
A comparison of antiangiogenic therapies for the prevention of liver metastases. J Surg Res (2005) 0.80
Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg (2013) 0.79
Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. J Surg Oncol (2014) 0.78
Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann Surg Oncol (2002) 0.78
Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP. J Gastrointest Surg (2012) 0.78
Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. Ann Surg Oncol (2011) 0.77
Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy? J Gastrointest Surg (2014) 0.77
Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study. J Gastrointest Surg (2008) 0.76
Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. HPB (Oxford) (2014) 0.75
Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance? HPB (Oxford) (2014) 0.75
Venous Thromboembolism Prophylaxis in Liver Surgery. J Gastrointest Surg (2016) 0.75
Hepatic tumor growth: target for angiogenesis inhibition? World J Surg (2005) 0.75
Simultaneous diaphragm and liver resection: a propensity-matched analysis of postoperative morbidity. J Am Coll Surg (2012) 0.75